NDLI: TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY

Content Provider	PubMed Central
Author	Rutka, James Park, Jun-bum Agnihotri, Sameer Brian, Golbourn Bertrand, Kelsey Luck, Amanda Sabha, Nesrin Sidney, Croul Smith, Christian A.
Copyright Year	2014
Abstract	BACKGROUND: The malignant astrocytoma is a highly proliferative and invasive neoplasm that infiltrates diffusely into regions of normal brain rendering total surgical resection impossible and effective local radiation therapy difficult. For truly significant advances to be made in the treatment of patients with malignant astrocytoma, we must develop a greater understanding of the molecular machinery driving invasion and identify novel treatment targets. METHODS: We recently compared gene-expression data of 400 invasion/migration genes by performing microarray analysis comparing 10 normal brain samples versus 51 mesenchymal GBM, which are highly invasive, and of poor prognosis. RESULTS: We identified over 141 significant genes with a 1.5 fold change (p-value <0.05, and a false discovery rate (q < 0.05) compared to normal brain. Of the 141 genes, the cofilin pathway, which disassembles actin filaments (namely LIMK1, LIMK2, CFL, CAP1) was highly up-regulated compared to normal brain. Furthermore we identified up-regulation of LIM domain kinase 1 and 2 (LIMK1/2) that phosphorylates and inactivates cofilin (CFL) in an additional data set comparing normal brain to GBM. Using a well-characterized tissue microarray of 20 GBM patients for which a central and a matched periphery sample was available we undertook immunohistochemical (IHC) analysis of LIMK1 and pCFL. We observed significant expression of LIMK1 in the periphery of the GBM compared to the center (11/20 in the periphery versus 2/20 in the center). Previously, we established that pCFL plays an integral role in GBM invasion. Consequently we explored how to target this pathway using small molecule inhibitors. We tested the LIMK1 and LIMK2 inhibitors BMS-5 and Cucurbitacin I. Both BMS-5 and Cucurbitacin I inhibited p-CFL at the protein level at 10uM and 100nM respectively in U87 cells. Using the MTT cell viability assay, we observed significant decrease in cell viability in U87 and T98G cells using doses of 10-20uM BMS-5 and 100nM-10uM Cucurbitacin I while no cytotoxic effect was seen in normal human astrocytes that lack LIMK expression. Both BMS-5 (10uM) and Cucurbitacin I (100nM) promoted increased adhesion in U87 and T98G cells. Interestingly, BMS-5 and Cucurbitacin I reduced migration and invasion of both U87 and T98G cells. CONCLUSIONS: Taken together, the use of LIMK inhibitors to target the invasive machinery in GBM are attractive candidates to move forward with in preclinical trials. SECONDARY CATEGORY: Tumor Biology.
Related Links	http://dx.doi.org/10.1093/neuonc/nou208.43
Starting Page	34
File Format	PDF
ISSN	15228517
e-ISSN	15235866
Journal	Neuro-Oncology
Issue Number	Suppl 3
Volume Number	16
Language	English
Publisher	Oxford University Press
Publisher Date	2014-07-01
Access Restriction	Open
Rights Holder	Oxford University Press
Subject Keyword	Cancer Research Oncology Clinical Neurology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Cancer Research Neurology (clinical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway

Integrative functional genomics identifies RINT1 as a novel GBM oncogene

Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM

Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas

CS-15NUCLEAR FACTOR I-A (NFIA) PROMOTES GBM SURVIVAL THROUGH NFkB PATHWAY

Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival

EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

NT-17TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) WITH AN ONCOLYTIC MEASLES VIRUS IN COMBINATION WITH INHIBITORS OF THE PI3-KINASE PATHWAY

TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY

Similar Documents

Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway

Integrative functional genomics identifies RINT1 as a novel GBM oncogene

Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM

Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas

CS-15NUCLEAR FACTOR I-A (NFIA) PROMOTES GBM SURVIVAL THROUGH NFkB PATHWAY

Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival

EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

NT-17TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) WITH AN ONCOLYTIC MEASLES VIRUS IN COMBINATION WITH INHIBITORS OF THE PI3-KINASE PATHWAY

TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY